InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（0 笔）
内部人交易记录
董事已披露买入
0
已披露卖出
0
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Explore the detailed record of transactions filed by Bogle Grant C., 董事. Insider active across 2 companies, notably Epizyme, Inc.. Cumulatively, 10 filings have been recorded. Activity tracked since 11 June 2021. The latest transaction was filed on 15 July 2026 (U). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Bogle Grant C.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报10 总计
3,714 股@ US$124.000.0047% mcap100.0% 占其流量Class A Common StockSEC:0001193125-26-305051:0
5,577 股Class A Common Stock - Restricted Stock UnitsSEC:0001193125-26-305051:1
3,444 股Class A Common StockSEC:0001646675-26-000002:0
2,647 股0Class A Common StockSEC:0000950170-25-088545:0
3,200 股0Class A Common StockSEC:0000950170-24-134328:0
84,170 股Common Stock, par value $0.0001SEC:0000899243-22-028851:0
800,000 股@ US$1.39100.0% 占其流量Common Stock, par value $0.0001SEC:0000899243-22-028421:0
87,500 股0Common Stock, par value $0.0001SEC:0000899243-22-004828:0
87,500 股0Common Stock, par value $0.0001SEC:0000899243-21-033401:0
8,060 股0Common Stock, par value $0.0001SEC:0000899243-21-023877:0
10 条申报中的 10 条
About Bogle Grant C.
Administrator of Nuvalent, Inc. and formerly President and CEO of Epizyme, Inc., Bogle Grant C. is a declarant with 10 filings in total. In the sampled recent filings, the buy and sell amounts are 0, the period runs from 2021-06-15 to 2026-07-15, and the most frequent transaction nature is Attribution.
